Explore more publications!

Press Releases

OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
ROSEN, A LONGSTANDING FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
Wash. Panel Says Healthcare Cost-Share Group Is An Insurer

Wash. Panel Says Healthcare Cost-Share Group Is An Insurer

Healthcare Realty Reports Fourth Quarter 2025 Results
Healthcare Realty Trust Announces $600 Million Commercial Paper Program
Lawmakers urge DHS to exempt health care workers from H-1B visa fee in AHA-supported letter
Rodent Activity Expands Beyond Coastal Cities, Exposing 1.2 Million Inland Californians to New Public Health Risks
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDT
CDC terminates grant for Minnesota meant to strengthen public health infrastructure

CDC terminates grant for Minnesota meant to strengthen public health infrastructure

ARDT WRITE OFFS: Hagens Berman Investigating Claims Against Ardent Health (ARDT) Over Alleged $97M Accounting Shock and “180-Day Cliff” Reserves
23.9 Miles: Distance, Not Doctors, Has Become the Biggest Barrier to Healthcare Access in California’s Rural Counties
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ardent Health, Inc. (ARDT) Shareholders
Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – RARE
Investors who lost money on Picard Medical, Inc.(PMI) should contact Levi & Korsinsky about pending Class Action - PMI
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit – AGL
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions